Onderneming Processa Pharmaceuticals Inc Other OTC
Aandelen
Farmaceutische producten
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Wendy Guy
FOU | Founder | 59 | 29-03-11 |
Sian Bigora
FOU | Founder | 63 | 29-03-11 |
David Young
FOU | Founder | 71 | 29-03-11 |
Patrick Lin
FOU | Founder | 58 | 29-03-11 |
George Ng
CEO | Chief Executive Officer | 49 | 08-08-23 |
Jim Stanker
DFI | Director of Finance/CFO | 67 | 05-09-18 |
Weifei Ye
CTO | Chief Tech/Sci/R&D Officer | - | - |
Kayla Parks
CTO | Chief Tech/Sci/R&D Officer | - | - |
Chief Tech/Sci/R&D Officer | - | - | |
Mary Nyberg
PRN | Corporate Officer/Principal | - | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
George Ng
CEO | Chief Executive Officer | 49 | 08-08-23 |
James Neal
BRD | Director/Board Member | 68 | 16-07-22 |
Justin Yorke
CHM | Chairman | 58 | 02-10-17 |
Patrick Lin
FOU | Founder | 58 | 29-03-11 |
David Young
FOU | Founder | 71 | 29-03-11 |
Director/Board Member | 66 | 11-07-22 | |
Geraldine Pannu
BRD | Director/Board Member | 54 | 13-02-20 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 2 863 007 | 2 512 049 ( 87,74 %) | 5 000 ( 0,1746 %) | 87,74 % |
Bedrijfsgegevens
Processa Pharmaceuticals, Inc.
7380 Coca Cola Drive Suite 106
21076, Hanover
+
http://www.processapharma.comSector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+40,73% | 739 mld. | |
+32,83% | 598 mld. | |
-6,30% | 353 mld. | |
+15,15% | 318 mld. | |
+4,05% | 285 mld. | |
+15,00% | 240 mld. | |
+9,78% | 210 mld. | |
-5,52% | 206 mld. | |
+6,17% | 164 mld. |